ERBB2 and breast carcinoma: As shown in Figure 2C, compared to MCF-10A cells, RUVBL1-AS1 was remarkably downregulated in HER2+ breast cancer cell lines (BT-474, and SK-BR-3 cell lines, p < 0.05).